FDA Considers Restricting or Banning Laparoscopic Morcellation
Open Access
- 13 October 2014
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 106 (10)
- https://doi.org/10.1093/jnci/dju339
Abstract
The U.S. Food and Drug Administration is considering restricting or banning morcellation in minimally invasive hysterectomies and myomectomies (removal of fibroids) because of new reports of higher incidence of undiagnosed sarcoma in women undergoing these procedures. Research now links morcellation to the spread, or upstaging, of undetectable gynecological cancers. In July, FDA convened a 2-day Obstetrics and Gynecology Devices Advisory Committee meeting to discuss risks and benefits of morcellation and to determine ways to reduce risk of upstaging cancers.Keywords
This publication has 0 references indexed in Scilit: